MGC Pharmaceuticals (ASX:MXC) - Co Founder, CEO & Managing Director, Roby Zomer
Co Founder, CEO & Managing Director, Roby Zomer
Source: MGC Pharmaceuticals
Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • MGC Pharmaceuticals (MXC) places its shares in a trading halt while it plans the details of an upcoming capital raising
  • The company will remain in the halt until December 2 or when more details are released, whichever occurs first
  • On November 25, MGC Pharma completed production of the €650,000 (A$1.02 million) ArtemiC order from Swiss PharmaCan
  • ArtemiC is MGC’s natural, immune-modulation formula that is made up of vitamin C and herbal extracts used to treat anti-inflammatory illnesses
  • Shares in MGC Pharma last traded at 4.1 cents on November 29

MGC Pharmaceuticals (MXC) has placed its shares in a trading halt while it plans the details of an upcoming capital raising.

The company will remain in the halt until December 2 or when more details are released, whichever occurs first.

MGC Pharma is yet to disclose how much it intends to raise or what it will use the money for once received.

On November 25, MGC Pharma completed production of the €650,000 (A$1.02 million) ArtemiC order from Swiss PharmaCan.

ArtemiC is made up of artemisinin, a drug from a fern-like plant that is used against malaria, and curcumin, a chemical that aids in anti-inflammatory and antioxidants.

It is then mixed with vitamin C and Boswell serrata, a herbal extract used to treat inflammatory illnesses.

Additional ArtemiC orders are set to continue following the grant of the Certificate of Free Trade in Germany and the European Union in September 2021.

Shares in MGC Pharma last traded at 4.1 cents on November 29. The company has a $99.33 million market cap.

MXC by the numbers
More From The Market Herald

" GWR Group (ASX:GWR) to launch fresh cap raise

Junior miner GWR Group (ASX:GWR) has started the week in a trading halt as it prepares…

" Artemis Resources (ASX:ARV) enters trading halt for capital raise and dual listing

Artemis Resources (ASX:ARV) has entered a trading halt regarding a capital raise and proposed dual AIM…

" Austin Metals (ASX:AYT) halts trade, eyes fresh capital

Austin Metals (ASX:AYT) has placed its shares in a trading halt in regards to an upcoming…
iSynergy Group (ASX:IS3) - CEO, Lawrence Teo

" I Synergy Group (ASX:IS3) raises capital for upcoming acquisition

I Synergy Group (ASX:IS3) commences the week in a trading halt as it plans a capital…